Study on hyperglycemia risk prediction with non-invasive data collected by wearable devices

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045126

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-04-15

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

case series:Patients will wear wearable devices and continuous glucose monitoring system at the same time.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes or prediabetes or normal glucose tolerance treated in the Endocrinology Department of Peking Union Medical College Hospital; 2. Aged >= 18 years; 3. The patient signs an informed consent form and has a smartphone.

Exclusion criteria

Exclusion criteria: 1. Patients with hemophilia or other severe coagulation disorders; 2. Patients with severe skin diseases; 3. Patients with mental illness; 4. Patients who are unable to cooperate with the study; 5. Patients with any other condition that doctors consider not suitable to participate in the study.

Design outcomes

Primary

Measure	Time frame
Total coincidence rate;	—

Secondary

Measure	Time frame
Single coincidence rate;	—

Countries

China

Contacts

Public ContactLI Wei

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

liw@pumch.cn+86 13651344883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026